• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在体外受到刺激而增殖的人类造血干细胞,在其S/G(2)/M转换过程中会丧失植入潜力,且不会重新进入G(0)期。

Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0).

作者信息

Glimm H, Oh I H, Eaves C J

机构信息

Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

出版信息

Blood. 2000 Dec 15;96(13):4185-93.

PMID:11110690
Abstract

An understanding of mechanisms regulating hematopoietic stem cell engraftment is of pivotal importance to the clinical use of cultured and genetically modified transplants. Human cord blood (CB) cells with lymphomyeloid repopulating activity in NOD/SCID mice were recently shown to undergo multiple self-renewal divisions within 6 days in serum-free cultures containing Flt3-ligand, Steel factor, interleukin 3 (IL-3), IL-6, and granulocyte colony-stimulating factor. The present study shows that, on the fifth day, the transplantable stem cell activity is restricted to the G(1) fraction, even though both colony-forming cells (CFCs) and long-term culture-initiating cells (LTC-ICs) in the same cultures are approximately equally distributed between G(0)/G(1) and S/G(2)/M. Interestingly, the G(0) cells defined by their low levels of Hoechst 33342 and Pyronin Y staining, and reduced Ki67 and cyclin D expression (representing 21% of the cultured CB population) include some mature erythroid CFCs but very few primitive CFCs, LTC-ICs, or repopulating cells. Although these findings suggest a cell cycle-associated change in in vivo stem cell homing, the cultured G(0)/G(1) and S/G(2)/M CD34(+) CB cells exhibited no differences in levels of expression of VLA-4, VLA-5, or CXCR-4. Moreover, further incubation of these cells for 1 day in the presence of a concentration of transforming growth factor beta(1) that increased the G(0)/G(1) fraction did not enhance detection of repopulating cells. The demonstration of a cell cycle-associated mechanism that selectively silences the transplantability of proliferating human hematopoietic stem cells poses both challenges and opportunities for the future improvement of ex vivo-manipulated grafts. (Blood. 2000;96:4185-4193)

摘要

了解调节造血干细胞植入的机制对于培养的和基因改造移植的临床应用至关重要。最近发现,在含有Flt3配体、干细胞因子、白细胞介素3(IL-3)、IL-6和粒细胞集落刺激因子的无血清培养中,在NOD/SCID小鼠中具有淋巴细胞系和髓细胞系重建活性的人脐带血(CB)细胞在6天内会经历多次自我更新分裂。本研究表明,在第5天,尽管同一培养物中的集落形成细胞(CFC)和长期培养起始细胞(LTC-IC)在G(0)/G(1)和S/G(2)/M之间大致均匀分布,但可移植干细胞活性仅限于G(1)期。有趣的是,通过低水平的Hoechst 33342和派洛宁Y染色以及降低的Ki67和细胞周期蛋白D表达所定义的G(0)细胞(占培养的CB群体的21%)包括一些成熟的红系CFC,但原始CFC、LTC-IC或重建细胞很少。尽管这些发现表明体内干细胞归巢存在与细胞周期相关的变化,但培养的G(0)/G(1)和S/G(2)/M期CD34(+)CB细胞在VLA-4、VLA-5或CXCR-4的表达水平上没有差异。此外,在增加G(0)/G(1)期比例的转化生长因子β(1)浓度存在下,将这些细胞进一步孵育1天并没有增强对重建细胞的检测。增殖的人造血干细胞移植能力选择性沉默的与细胞周期相关机制的证明,对未来体外操作移植物的改进既带来了挑战也带来了机遇。(《血液》。2000年;96:4185 - 4193)

相似文献

1
Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0).在体外受到刺激而增殖的人类造血干细胞,在其S/G(2)/M转换过程中会丧失植入潜力,且不会重新进入G(0)期。
Blood. 2000 Dec 15;96(13):4185-93.
2
Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice.非肥胖糖尿病/严重联合免疫缺陷小鼠中人类动员外周血CD34(+)细胞再增殖能力的细胞周期相关变化。
Blood. 1998 Oct 15;92(8):2641-9.
3
In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.体外扩增的人CD34(+)脐血细胞长期多系(髓系、B细胞、自然杀伤细胞和T细胞)重建能力的体外和体内证据。
Exp Hematol. 2000 Dec;28(12):1470-80. doi: 10.1016/s0301-472x(00)00557-9.
4
Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood.来自新生儿脐带血的人类干祖细胞比来自动员的成人血液的干祖细胞具有更强的造血扩增能力。
Exp Hematol. 2002 Jul;30(7):816-23. doi: 10.1016/s0301-472x(02)00818-4.
5
Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood.脐带血NOD/SCID重建造血能力和第6周的长期培养起始细胞(CAFC)的成功短期体外扩增。
Leukemia. 2000 Nov;14(11):1944-53. doi: 10.1038/sj.leu.2401917.
6
Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells.移植体外扩增的人CD34(+)脐血细胞的非肥胖糖尿病/重症联合免疫缺陷小鼠的植入延迟。
Blood. 1999 Feb 1;93(3):1097-105.
7
Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture.人类体内再增殖造血细胞在短期培养中多次自我更新分裂的直接证据。
Blood. 1999 Oct 1;94(7):2161-8.
8
Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion.体外扩增后人外周血CD34(+)细胞中干细胞表型与NOD/SCID重建造血活性之间的解离
Exp Hematol. 2001 Dec;29(12):1465-73. doi: 10.1016/s0301-472x(01)00750-0.
9
Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts.用白细胞介素-3(IL-3)、白细胞介素-6(IL-6)、白细胞介素-11(IL-11)和干细胞因子对小鼠骨髓细胞进行体外扩增,会导致其在受辐照宿主中的植入受损。
Blood. 1996 Jan 1;87(1):30-7.
10
Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.在含有早期效应细胞因子的限定无血清培养基(QBSF-60)中对CD34+脐带血细胞进行体外扩增。
J Hematother Stem Cell Res. 1999 Dec;8(6):609-18. doi: 10.1089/152581699319777.

引用本文的文献

1
Engineered packaging cell line for the enhanced production of baboon-enveloped retroviral vectors.用于增强狒包膜逆转录病毒载体生产的工程包装细胞系。
Mol Ther Nucleic Acids. 2024 Nov 13;35(4):102389. doi: 10.1016/j.omtn.2024.102389. eCollection 2024 Dec 10.
2
WBP1L regulates hematopoietic stem cell function and T cell development.WBP1L 调节造血干细胞功能和 T 细胞发育。
Front Immunol. 2024 Nov 1;15:1421512. doi: 10.3389/fimmu.2024.1421512. eCollection 2024.
3
Advancements in Hematopoietic Stem Cell Gene Therapy: A Journey of Progress for Viral Transduction.
造血干细胞基因治疗的进展:病毒转导的进步之旅。
Cells. 2024 Jun 15;13(12):1039. doi: 10.3390/cells13121039.
4
Adaptation to ex vivo culture reduces human hematopoietic stem cell activity independently of the cell cycle.适应体外培养会降低人造血干细胞的活性,而与细胞周期无关。
Blood. 2024 Aug 15;144(7):729-741. doi: 10.1182/blood.2023021426.
5
CD38 promotes hematopoietic stem cell dormancy.CD38促进造血干细胞休眠。
PLoS Biol. 2024 Feb 29;22(2):e3002517. doi: 10.1371/journal.pbio.3002517. eCollection 2024 Feb.
6
Removal of innate immune barriers allows efficient transduction of quiescent human hematopoietic stem cells.去除先天免疫屏障可实现对静止期人类造血干细胞的有效转导。
Mol Ther. 2024 Jan 3;32(1):124-139. doi: 10.1016/j.ymthe.2023.11.020. Epub 2023 Nov 20.
7
Inhibition of Gap Junction Formation Prior to Implantation of Bone Marrow-Derived Mesenchymal Cells Improves Function in the Ischemic Myocardium.在骨髓间充质细胞植入前抑制缝隙连接形成可改善缺血心肌功能。
Int J Mol Sci. 2023 Jun 2;24(11):9653. doi: 10.3390/ijms24119653.
8
Homology-Directed-Repair-Based Genome Editing in HSPCs for the Treatment of Inborn Errors of Immunity and Blood Disorders.基于同源定向修复的造血干细胞基因组编辑用于治疗先天性免疫缺陷和血液疾病
Pharmaceutics. 2023 Apr 24;15(5):1329. doi: 10.3390/pharmaceutics15051329.
9
An improved medium formulation for efficient gene editing, expansion and engraftment of hematopoietic stem and progenitor cells.一种用于造血干细胞和祖细胞高效基因编辑、扩增及植入的改良培养基配方。
Mol Ther Methods Clin Dev. 2023 Feb 28;29:58-69. doi: 10.1016/j.omtm.2023.02.014. eCollection 2023 Jun 8.
10
Stemness-related genes revealed by single-cell profiling of naïve and stimulated human CD34 cells from CB and mPB.通过对来自 CB 和 mPB 的幼稚和刺激的人 CD34 细胞进行单细胞分析揭示的干性相关基因。
Clin Transl Med. 2023 Jan;13(1):e1175. doi: 10.1002/ctm2.1175.